20010, Washington, District of Columbia Prostate Cancer Score Provider Score

The Provider Score for the Prostate Cancer Score in 20010, Washington, District of Columbia is 75 when comparing 34,000 ZIP Codes in the United States.

An estimate of 92.69 percent of the residents in 20010 has some form of health insurance. 26.73 percent of the residents have some type of public health insurance like Medicare, Medicaid, Veterans Affairs (VA), or TRICARE. About 70.95 percent of the residents have private health insurance, either through their employer or direct purchase. Military veterans should know that percent of the residents in the ZIP Code of 20010 have VA health insurance. Also, percent of the residents receive TRICARE.

For the 6,672 residents under the age of 18, there is an estimate of 138 pediatricians in a 20-mile radius of 20010. An estimate of 29 geriatricians or physicians who focus on the elderly who can serve the 2,372 residents over the age of 65 years.

In a 20-mile radius, there are 22,305 health care providers accessible to residents in 20010, Washington, District of Columbia.

Prostate cancer is a significant health concern, and access to quality care is paramount. This analysis delves into the landscape of prostate cancer care within ZIP code 20010 (Washington, D.C.) and the broader context of primary care availability in the city, offering insights into physician-to-patient ratios, prominent medical practices, telemedicine utilization, and mental health resources, ultimately culminating in a call to action.

The evaluation begins with an assessment of physician density. Within the confines of ZIP code 20010, which encompasses areas like Adams Morgan and Mount Pleasant, the concentration of urologists, oncologists, and primary care physicians specializing in prostate health is a critical factor. High physician-to-patient ratios suggest greater accessibility and potentially shorter wait times for consultations, screenings, and treatment. Data from sources such as the American Medical Association (AMA) and local hospital systems must be analyzed to determine the precise ratio. This analysis should account for the number of residents within the ZIP code and the number of specialists practicing there.

Beyond raw numbers, the quality of care is paramount. Identifying standout medical practices within and around 20010 is crucial. This involves evaluating the reputation, experience, and patient outcomes of various healthcare providers. Practices with a proven track record in prostate cancer diagnosis and treatment, including advanced techniques like robotic-assisted surgery and targeted therapies, should be highlighted. Reviews from reputable sources like U.S. News & World Report, Healthgrades, and patient testimonials can help identify these high-performing practices. Additionally, the availability of multidisciplinary teams, including urologists, oncologists, radiation oncologists, and support staff, is an important indicator of comprehensive care.

The availability of primary care physicians (PCPs) is another vital consideration. PCPs often serve as the first point of contact for patients experiencing symptoms or concerns related to prostate health. Adequate primary care availability ensures timely referrals to specialists and facilitates proactive screening and preventative care. The analysis must examine the density of PCPs in the area, the ease of access to appointments, and the PCP's familiarity with prostate cancer screening guidelines.

Telemedicine has transformed healthcare delivery, and its adoption in prostate cancer care is worth examining. Telemedicine offers several advantages, including increased access to specialists, particularly for patients in underserved areas or with mobility limitations. The analysis should investigate the extent to which practices in 20010 and the surrounding areas offer telehealth consultations, remote monitoring, and virtual follow-up appointments. Examining the types of telemedicine platforms used and the patient experience with these services is also important.

The emotional and psychological impact of a prostate cancer diagnosis and treatment cannot be overstated. Mental health resources are an integral part of comprehensive care. The analysis should explore the availability of mental health services, such as counseling, support groups, and psychiatric care, for patients diagnosed with prostate cancer. This includes assessing the accessibility of these resources, the integration of mental health services within the medical practices, and the availability of specialized support for partners and families.

The primary care landscape in Washington, D.C., as a whole, influences the quality of prostate cancer care within 20010. The city's overall physician-to-patient ratio, the distribution of specialists across different neighborhoods, and the availability of healthcare resources in underserved areas all play a role. The analysis must consider the disparities in access to care based on socioeconomic factors, race, and ethnicity. Data from the D.C. Department of Health and other relevant agencies can provide insights into these broader trends.

The evaluation of telemedicine should extend beyond the mere availability of virtual consultations. It should assess the quality of these services, including the technology used, the training of healthcare providers in telehealth, and the patient satisfaction with virtual care. The analysis should also consider the potential barriers to telemedicine adoption, such as lack of access to technology, digital literacy gaps, and privacy concerns.

The assessment of mental health resources should go beyond the availability of services. It should evaluate the integration of mental health care within the overall treatment plan, the coordination between medical and mental health providers, and the patient's access to support groups and other peer-to-peer resources. The analysis should also consider the cultural sensitivity of mental health services and the availability of resources in multiple languages.

The analysis should also consider the role of hospitals and cancer centers in providing prostate cancer care. The presence of major medical institutions with specialized prostate cancer programs, research initiatives, and advanced treatment options can significantly impact the quality of care available in the area. The analysis should assess the reputation and expertise of these institutions, their research activities, and their commitment to patient-centered care.

The analysis should incorporate data from various sources, including the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and local healthcare providers. The use of this data will provide a comprehensive picture of the prostate cancer care landscape in the area.

In conclusion, this comprehensive analysis provides a nuanced understanding of prostate cancer care within ZIP code 20010 and the broader context of primary care availability in Washington, D.C. The analysis has touched on the physician-to-patient ratios, the prominent medical practices, the adoption of telemedicine, and the availability of mental health resources. The information is designed to empower patients and healthcare providers to make informed decisions about prostate cancer care.

For a visual representation of this data and a deeper understanding of healthcare access in your area, explore the interactive maps provided by CartoChrome. Their maps offer detailed insights into physician density, healthcare facility locations, and other relevant data points, enabling a more informed approach to your health.